CURE ETF Rallies 20%

ETFS S&P Biotech is under Algo Engine buy conditions and was added to our “high conviction” model following the low formed at $52.

The ETF has since rallied 20% and the buying momentum among biotech stocks remains strong.

You’re not a member!  Trial today

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.